https://theprint.in/health/new-drug-for-acute-leukaemia-leads-53-to-complete-or-partial-remission-in-us-trials/1445557/
0
0
42 words
0
Comments
Revumenib found to be promising in 2 studies by US researchers published in 'Nature' Wednesday. Leukaemia accounted for nearly 4% of global cancer deaths in 2020.
You are the first to view
Create an account or login to join the discussion